Navigation Links
Auxogyn And Reproductive Medicine Associates of New Jersey Partner To Advance in vitro fertilization Research
Date:6/19/2012

MENLO PARK, Calif., June 19, 2012 /PRNewswire/ -- Auxogyn, Inc., a company at the forefront of reproductive health innovation, today announced the commencement of a groundbreaking research study with Reproductive Medicine Associates of New Jersey (RMANJ), an internationally-renowned fertility clinic that has pioneered and successfully implemented cutting-edge clinical advancements to more accurately detect healthy embryos for patients undergoing in vitro fertilization (IVF).

(Logo: http://photos.prnewswire.com/prnh/20120605/SF18545LOGO)

"Auxogyn is committed to funding and conducting rigorous scientific research to continually improve outcomes for IVF patients," said Lissa Goldenstein, president and chief executive officer of Auxogyn. "We are pleased to partner with RMANJ and believe this study may expand our understanding of embryo development dramatically, potentially leading to further improvement in our ability to detect healthy embryos during assisted reproduction procedures."

Patients enrolled in the study will be those who have determined, after consultation with their physician, to undergo pre-implantation genetic diagnosis using Comprehensive Chromosome Screening (CCS), a new rapid-method 24-chromosome screening technique first implemented at RMANJ. During the study, all embryos will be monitored using the Eeva™ (Early Embryo Viability Assessment) Test, a non-invasive test developed by Auxogyn to record and quantitatively analyze embryo development against scientifically- and clinically-validated cell-division time periods.

"Our objectives at RMANJ are two-fold: to increase the healthy live birth rate for those undergoing assisted reproductive procedures, and to decrease the multiple embryo transfer rate, thereby reducing multiple pregnancies," commented Richard T. Scott, Jr., M.D., F.A.C.O.G., H.C.L.D., founding partner of RMANJ. "Through this collaborative research study with Auxogyn, we will explore new, previously unidentified factors that cause one euploid embryo to implant where another seemingly healthy embryo does not. These discoveries could directly impact clinical practice in the future, moving us closer to the ultimate goal of the IVF field – one embryo, one healthy baby."

About Reproductive Medicine Associates of New Jersey

Reproductive Medicine Associates of New Jersey have pioneered and successfully implemented a cutting-edge technology, known as Comprehensive Chromosome Screening (CCS) to more accurately detect healthy embryos that will lead to successful pregnancies and ultimately healthy babies. Other centers have attempted similar testing methods, but RMANJ is the only fertility center in the world to have developed a system of unprecedented accuracy, fully validated through years of rigorous clinical research. RMANJ's Comprehensive Chromosome Screening offers advanced embryo selection with extreme accuracy by detecting and avoiding use of embryos with chromosomal abnormalities prior to transfer and pregnancy. 

The fertility experts at RMANJ have among the highest IVF success rates in the country. Since 1999, they have helped bring more than 20,000 babies to loving families. In addition to serving as the Division of Reproductive Endocrinology at Robert Wood Johnson University Medical School in New Brunswick, NJ, the practice has six locations in New Jersey. For more information please call RMANJ at 973-656-2089, or visit www.rmanj.com.

About Auxogyn

Auxogyn, Inc. is focused on advancing the field of reproductive health through its uniquely-combined knowledge of early human developmental biology, advanced computer vision technology and best clinical practices. The company's first product, the Eeva™ Test, is designed to provide quantitative information regarding embryo development to assist IVF clinicians in optimizing the treatment path for their patients undergoing IVF procedures.  Auxogyn is privately held and funded by Kleiner Perkins Caufield & Byers, Merck Serono Ventures, SR One and TPG Biotech. For more information regarding Auxogyn please visit www.auxogyn.com.


'/>"/>
SOURCE Auxogyn, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Auxogyn Completes $20 Million In Series A Funding
2. Neuralstem CEO to Present at the World Stem Cells and Regenerative Medicine Congress in London
3. Alliance for Safe Biologic Medicines Chairman Urges FDA to Ensure that Patient Safety is the Cornerstone of Biosimilar Pathway
4. First targeted and programmable nanomedicine to show clinical antitumor effects published
5. CNIO researchers take part in the most comprehensive personalized medicine study performed to date
6. Dr. Alan Gaby to Present Nutritional Medicine Updates in a Nationwide Tour
7. Smart, self-healing hydrogels open far-reaching possibilities in medicine, engineering
8. New Study Building Framework to Bring Personalized Medicine to the Clinic
9. bioTheranostics Launches Precision Medicine Biomarkers for Tumor Pathway Interrogation
10. Palm Beach Residents to Learn How the Future of Regenerative Medicine Will Combat Aging
11. PinneyAssociates Announces Senior Staff Promotions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... SANTA BARBARA, CALIFORNIA (PRWEB) , ... April 20, 2017 , ... ... process optimization firm for the life sciences and healthcare industries, is pleased to announce ... of the new established USDM subsidiary “USDM Europe GmbH” based in Germany. , ...
(Date:4/20/2017)... CA (PRWEB) , ... April 20, 2017 , ... ... of clinical trials worldwide, announced today that they were named one of the ... which covers the latest developments in the pharmaceutical industry. , “We take pride in ...
(Date:4/19/2017)... ... 2017 , ... The Vibrating Orifice Aerosol Generator (VOAG) was ... droplets of known diameters for research applications such as for calibrating droplet measuring ... monodisperse droplets. , The VOAG requires forcing liquid out of an orifice ...
(Date:4/19/2017)... Waltham, MA (PRWEB) , ... April 19, 2017 ... ... of a $1.5M Series A-1 financing round. This event adds to several other ... establishment of its’ Executive and Scientific Teams. , ThermaGenix will use ...
Breaking Biology Technology:
(Date:3/24/2017)... Mar 24, 2017 Research and Markets has ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... at a CAGR of around 15.1% over the next decade to ... report analyzes the market estimates and forecasts for all the given ...
(Date:3/22/2017)... 2017 Vigilant Solutions , a vehicle ... agencies, announced today the appointment of retired FBI special ... safety business development. Mr. Sheridan brings more ... a focus on the aviation transportation sector, to his ... Mr. Sheridan served as the Aviation Liaison Agent Coordinator ...
(Date:3/9/2017)... Australia , March 9, 2017 4Dx ... prestigious World Lung Imaging Workshop at the University of ... was invited to deliver the latest data to world ... recognised event brings together leaders at the forefront of ... in lung imaging. "The quality of ...
Breaking Biology News(10 mins):